Guanhao Biotech Co.,Ltd. (SHE:300238)
China
· Delayed Price · Currency is CNY 16.01
+0.34 (2.17%)
Mar 10, 2026, 11:44 AM CST
Guanhao Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,155 | 3,192 | 3,596 | 2,726 | 4,913 | 6,666 | Upgrade
|
| Market Cap Growth | 21.57% | -11.21% | 31.91% | -44.52% | -26.29% | 31.55% | Upgrade
|
| Enterprise Value | 4,055 | 3,108 | 3,457 | 2,660 | 4,896 | 6,593 | Upgrade
|
| Last Close Price | 15.67 | 12.04 | 13.56 | 10.28 | 18.53 | 25.14 | Upgrade
|
| PE Ratio | 158.37 | 116.44 | 115.96 | - | 66.68 | 143.06 | Upgrade
|
| Forward PE | - | 78.31 | 78.31 | 78.31 | 78.31 | 78.31 | Upgrade
|
| PS Ratio | 10.58 | 8.46 | 8.90 | 7.23 | 10.05 | 15.26 | Upgrade
|
| PB Ratio | 8.42 | 6.83 | 7.88 | 6.33 | 6.57 | 9.30 | Upgrade
|
| P/TBV Ratio | 8.34 | 6.80 | 8.14 | 6.85 | 9.72 | 15.08 | Upgrade
|
| P/FCF Ratio | 230.98 | - | 15555.62 | 91.44 | 41.75 | 66.04 | Upgrade
|
| P/OCF Ratio | 59.49 | 64.42 | 66.40 | 38.40 | 40.14 | 64.19 | Upgrade
|
| EV/Sales Ratio | 10.32 | 8.24 | 8.55 | 7.05 | 10.01 | 15.09 | Upgrade
|
| EV/EBITDA Ratio | 62.94 | 55.91 | 56.53 | - | 51.80 | 94.57 | Upgrade
|
| EV/EBIT Ratio | 104.80 | 88.16 | 87.19 | - | 71.83 | 158.72 | Upgrade
|
| EV/FCF Ratio | 225.43 | - | 14955.89 | 89.24 | 41.60 | 65.32 | Upgrade
|
| Debt / Equity Ratio | 0.24 | 0.23 | 0.12 | 0.18 | 0.20 | 0.29 | Upgrade
|
| Debt / EBITDA Ratio | 1.87 | 1.75 | 0.80 | - | 1.42 | 2.98 | Upgrade
|
| Debt / FCF Ratio | 6.68 | - | 236.51 | 2.65 | 1.29 | 2.06 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | 0.00 | -0.11 | -0.11 | -0.01 | 0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.36 | 0.03 | -0.82 | 1.50 | -0.08 | 0.74 | Upgrade
|
| Net Debt / FCF Ratio | -1.18 | -0.06 | -218.35 | -1.58 | -0.07 | 0.51 | Upgrade
|
| Asset Turnover | 0.52 | 0.53 | 0.60 | 0.43 | 0.44 | 0.38 | Upgrade
|
| Inventory Turnover | 1.07 | 1.05 | 1.32 | 1.58 | 0.94 | 1.11 | Upgrade
|
| Quick Ratio | 1.25 | 0.95 | 1.04 | 1.10 | 1.06 | 0.95 | Upgrade
|
| Current Ratio | 1.98 | 1.49 | 1.55 | 1.58 | 1.66 | 1.45 | Upgrade
|
| Return on Equity (ROE) | 3.40% | 3.60% | 4.75% | -55.57% | 6.93% | 5.82% | Upgrade
|
| Return on Assets (ROA) | 3.21% | 3.08% | 3.67% | -3.89% | 3.82% | 2.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.64% | 4.78% | 6.60% | -9.80% | 5.59% | 4.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.20% | 6.10% | 7.80% | -11.40% | 8.10% | 5.00% | Upgrade
|
| Earnings Yield | 0.63% | 0.86% | 0.86% | -11.29% | 1.50% | 0.70% | Upgrade
|
| FCF Yield | 0.43% | -0.83% | 0.01% | 1.09% | 2.40% | 1.51% | Upgrade
|
| Payout Ratio | - | 8.99% | 3.89% | - | 9.46% | 30.40% | Upgrade
|
| Buyback Yield / Dilution | 2.89% | -6.11% | 2.63% | -0.83% | -1.66% | 2.65% | Upgrade
|
| Total Shareholder Return | 2.89% | -6.11% | 2.63% | -0.83% | -1.66% | 2.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.